| 1 |
Ferrous Ascorbate & Folic Acid Tablets |
Each film coated tablet contains:- Ferrous Ascorbate eq. to elemental Iron 100mg Folic Acid IP 1.5 mg Excipients q.s Approved colour used |
| 2 |
Azithromycin Tablets IP |
Each film coated tablet contains:- Azithromycin Dihydrate IP eq. to Azithromycin Anhydrous 500mg Excipients q.s Approved colour used |
| 3 |
Azithromycin Tablets IP |
Each film coated tablet contains:- Azithromycin Dihydrate IP eq. to Azithromycin Anhydrous 250mg Excipients q.s Approved colour used |
| 4 |
Folic Acid Tablets IP |
Each uncoated tablet contains:- Folic Acid IP 5 mg Excipients q.s Approved colour used |
| 5 |
Fluconazole Tablets IP |
Each uncoated tablet contains:- Fluconazole IP 150 mg Excipients q.s Approved colour used |
| 6 |
Pantoprazole Tablets IP |
Each enteric coated tablet contains:- Pantoprazole Sodium IP eq. to Pantoprazole 40 mg Excipients q.s Approved colour used |
| 7 |
Pantoprazole & Domperidone Tablets |
Each enteric coated tablet contains:- Pantoprazole Sodium IP eq. to Pantoprazole 40mg Domperidone IP 10 mg Excipients q.s Approved colour used |
| 8 |
Calcium Carbonate & Alfacalcidol Tablets |
Each film coated tablet contains:- Calcium Carbonate (Oyster shell) 1250 mg eq. to Elemental Calcium 500mg Alfacalcidol IP 0.25 mcg Excipients q.s Approved colour used |
| 9 |
Levocetirizine Tablets IP |
Each film coated tablet contains:- Levocetirizine Dihydrochloride IP 5 mg Excipients q.s Approved colour used |
| 10 |
Drotaverine Hydrochloride & Mefenamic Acid Tablets |
Each film coated tablet contains:- Drotaverine Hydrochloride IP 80 mg Mefenamic Acid IP 250 mg Excipients q.s Approved colour used |
| 11 |
Deflazacort Tablets |
Each uncoated tablet contains:- Deflazacort 6 mg Excipients q.s Approved colour used |
| 12 |
Deflazacort Tablets |
Each uncoated tablet contains:- Deflazacort 30 mg Excipients q.s Approved colour used |
| 13 |
Levofloxacin Tablets IP |
Each film coated tablet contains:- Levofloxacin Hemihydrate IP eq. to Levofloxacin 500mg Excipients q.s (Not for Prostatitis); Approved colour used |
| 14 |
Levofloxacin Tablets IP |
Each film coated tablet contains:- Levofloxacin Hemihydrate IP eq. to Levofloxacin 750 mg Excipients q.s (Not for Prostatitis) ; Approved colour used |
| 15 |
Rabeprazole Tablets IP |
Each enteric coated tablet contains:- Rabeprazole Sodium IP 20 mg Excipients q.s Approved colour used |
| 16 |
Rabeprazole & Domperidone Tablets |
Each enteric coated tablet contains:- Rabeprazole Sodium IP 20 mg Domperidone IP 10 mg Excipients q.s Approved colour used |
| 17 |
Guaiphenesin, Bromhexine Hydrochloride, Chlorpheniramine Maleate, Phenylephrine Hydrochloride & Paracetamol Tablets |
Each uncoated tablet contains:- Guaiphenesin IP 50 mg Bromhexine Hydrochloride IP 4 mg Chlorpheniramine Maleate IP 4 mg Phenylephrine Hydrochloride IP 5 mg Paracetamol IP 325 mg Excipients q.s Approved colour used |
| 18 |
Ciprofloxacin Tablets IP |
Each film coated tablet contains:- Ciprofloxacin Hydrochloride IP eq. to Ciprofloxacin 250mg Excipients q.s Approved colour used |
| 19 |
Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets |
Each film coated tablet contains:- Diclofenac Potassium BP 50 mg Paracetamol IP 325 mg Serratiopeptidase IP 15 mg eq. to 30000 units of enzymetic activity (as enteric coated granules) Excipients q.s Approved colour used |
| 20 |
Methylprednisolone Tablets IP |
Each uncoated tablet contains:- Methylprednisolone IP 8 mg Excipients q.s Approved colour used |
| 21 |
Methylprednisolone Tablets IP |
Each uncoated tablet contains:- Methylprednisolone IP 16 mg Excipients q.s Approved colour used |
| 22 |
Methylprednisolone Tablets IP |
Each uncoated tablet contains:- Methylprednisolone IP 4 mg Excipients q.s Approved colour used |
| 23 |
Ofloxacin & Ornidazole Tablets |
Each film coated tablet contains:- Ofloxacin IP 200 mg Ornidazole IP 500 mg Excipients q.s Approved colour used |
| 24 |
Cetirizine Dihydrochloride , Paracetamol, Phenylephrine Hydrochloride & Caffeine Tablets |
Each uncoated tablet contains:- Cetirizine Dihydrochloride IP 10 mg Paracetamol IP 325 mg Phenylephrine Hydrochloride IP 10 mg caffeine (Anhydrous) IP 30 mg Excipients q.s Approved colour used |
| 25 |
Nimesulide & Paracetamol Tablets (Not for Children bleow the age of 12 years |
Each uncoated tablet contains:- Nimesulide BP 100 mg Paracetamol IP 325 mg Excipients q.s Approved colour used |
| 26 |
Ondansetron Orally Disintegrating Tablets IP |
Each uncoated Orally Disintegrating tablet contains:- Ondansetron Hydrochloride IP eq. to Ondansetron 4 mg Excipients q.s Approved colour used |
| 27 |
Albendazole & Ivermectin Tablets |
Each uncoated Chewable tablet contains:- Albendazole IP 400 mg Ivermectin IP 12 mg Excipients q.s Approved colour used |
| 28 |
Ofloxacin Tablets IP |
Each film coated tablet contains:- Ofloxacin IP 200 mg Excipients q.s Approved colour used |
| 29 |
Ofloxacin Tablets IP |
Each film coated tablet contains:- Ofloxacin IP 400 mg Excipients q.s Approved colour used |
| 30 |
Ciprofloxacin Tablets IP |
Each film coated tablet contains:- Ciprofloxacin Hydrochloride IP eq. to Ciprofloxacin 500mg Excipients q.s Approved colour used |
| 31 |
Diclofenac Potassium , Paracetamol & Chlorzoxazone Tablets |
Each film coated tablet contains:- Diclofenac Potassium BP 50 mg Paracetamol IP 325 mg Chlorzoxazone USP 250 mg Excipients q.s Approved colour used |
| 32 |
L-Ornithine L-Aspartate & Pancreatin Tablets |
Each film coated tablet contains:- L-Ornithine L-Aspartate 150 mg Pancreatin IP 100 mg Excipients q.s Approved colour used |
| 33 |
Diclofenac Potassium & Serratiopeptidase Tablets |
Each film coated tablet contains:- Diclofenac Potassium BP 50 mg Serratiopeptidase IP 10 mg eq. to 20000 units of enzymetic activity (as enteric coated granules) Excipients q.s Approved colour used |
| 34 |
Pantoprazole & Domperidone Tablets |
Each enteric coated tablet contains:- Pantoprazole Sodium IP eq. to Pantoprazole 20 mg Domperidone IP 10 mg Excipients q.s Approved colour used |
| 35 |
Levocetirizine Dihydrochloride & Montelukast Tablets |
Each film coated tablet contains:- Levocetirizine Dihydrochloride IP 5 mg Montelukast Sodium IP eq.to Montelukast 10 mg Excipients q.s Approved colour used |
| 36 |
Aceclofenac Paracetamol & Serratiopeptidase Tablets |
Each film coated tablet contains:- Aceclofenac IP 100 mg Paracetamol IP 325 mg Serratiopeptidase IP 15 mg eq. to 30000 units of enzymetic activity (as enteric coated granules) Excipients q.s Approved colour used |
| 37 |
Diclofenac Potassium , Paracetamol & Serratiopeptidase Tablets |
Each film coated tablet contains:- Diclofenac Potassium BP 50 mg Paracetamol IP 325 mg Serratiopeptidase IP 10 mg eq. to 20000 units of enzymetic activity (as enteric coated granules) Excipients q.s Approved colour used |
| 38 |
Calcium Citrate, Magnesium Hydroxide & zinc Sulphate Tablets |
Each film coated tablet contains:- Calcium Citrate USP 1000 mg Magnesium Hydroxide IP eq. to elemental Magnesium 100mg Zinc Sulphate Monohydrate IP eq. to elemental Zinc 4 mg Excipients q.s Approved colour used |
| 39 |
Aceclofenac & Paracetamol Tablets |
Each film coated tablet contains:- Aceclofenac IP 100 mg Paracetamol IP 325 mg Excipients q.s Approved colour used |
| 40 |
Aceclofenac , Paracetamol & Chlorzoxazone Tablets |
Each film coated tablet contains:- Aceclofenac IP 100 mg Paracetamol IP 325 mg Chlorzoxazone USP 250 mg Excipients q.s Approved colour used |
| 41 |
Mefenamic Acid & Dicyclomine Hydrochloride Tablets |
Each uncoated tablet contains:- Mefenamic Acid IP 250 mg Dicyclomine Hydrochloride IP 10 mg Excipients q.s Approved colour used |
| 42 |
Diclofenac Potassium & Paracetamol Tablets |
Each film coated tablet contains:- Diclofenac Potassium BP 50 mg Paracetamol IP 325 mg Excipients q.s Approved colour used |
| 43 |
Albendazole Tablets IP |
Each uncoated Chewable tablet contains:- Albendazole IP 400 mg Excipients q.s Approved colour used |
| 44 |
Levocetirizine Dihydrochloride , Paracetamol, Phenylephrine Hydrochloride & caffeine tablets |
Each uncoated tablet contains:- Levocetirizine Dihydrochloride IP 2.5 mg Paracetamol IP 325 mg Phenylephrine Hydrochloride IP 10 mg caffeine (Anhydrous) IP 30 mg Excipients q.s Approved colour used |
| 45 |
Calcium Citrate Malate, Magnesium Hydroxide, Vitamin D3 & zinc Sulphate Tablets |
Each film coated tablet contains:- Calcium Citrate Malate 1000 mg Magnesium Hydroxide IP eq. to elemental Magnesium 100mg Vitamin D3 (Stabilised) IP 200 IU Zinc Sulphate Monohydrate IP eq. to elemental Zinc 4 mg eq. to elemental Zinc q.s Approved colour used |
| 46 |
Calcium Citrate, Magnesium Hydroxide, Vitamin D3 & Zinc Sulphate Tablets |
Each film coated tablet contains:- Calcium Citrate USP 1000 mg Magnesium Hydroxide IP eq. to elemental Magnesium 100mg Vitamin D3 (Stabilised) IP 200 IU Zinc Sulphate Monohydrate IP eq. to elemental Zinc 4 mg Excipients q.s Approved colour used |
| 47 |
Levofloxacin & Ornidazole Tablets |
Each film coated tablet contains:- Levofloxacin Hemihydrate IP eq. to Levofloxacin 250mg Ornidazole IP 500 mg Excipients q.s Approved colour used |
| 48 |
Artemether & Lumefantrine Tablets |
Each uncoated tablet contains:- Artemether IP 80 mg Lumefantrine 480 mg Excipients q.s Approved colour used |
| 50 |
Atorvastatin Tablets IP |
Each film coated tablet contains:- Atorvastatin Calcium IP eq. to Atorvastatin 5 mg Excipients q.s Approved colour used |
| 51 |
Atorvastatin Tablets IP |
Each film coated tablet contains:- Atorvastatin Calcium IP eq. to Atorvastatin 10 mg Excipients q.s Approved colour used |
| 52 |
Doxofylline Tablets IP |
Each uncoated tablet contains:- Doxofylline IP 400 mg Excipients q.s Approved colour used |
| 53 |
Albendazole & Ivermectin Tablets |
Each uncoated Chewable tablet contains:- Albendazole IP 400 mg Ivermectin IP 6 mg Excipients q.s Approved colour used |
| 54 |
Doxylamine Succinate , Pyridoxine Hydrochloride & Folic Acid Tablets |
Each enteric coated tablet contains:- Doxylamine succinate USP 20 mg Pyridoxine Hydrochloride IP 20 mg Folic Acid IP 5 mg Excipients q.s Approved colour used |
| 55 |
Amlodipine Besylate Tablets IP |
Each uncoated tablet contains:- Amlodipine Besylate IP eq.to Amlodipine 5 mg Excipients q.s Approved colour used |
| 56 |
Aceclofenac Tablets IP |
Each film coated tablet contains:- Aceclofenac IP 100 mg Excipients q.s Approved colour used |
| 57 |
Nimesulide & Serratiopeptidase Tablets (Not for Children bleow the age of 12 years |
Each uncoated tablet contains:- Nimesulide BP 100 mg Serratiopeptidase IP 15 mg eq. to 30000 units of enzymetic activity (as enteric coated granules) Excipients q.s Approved colour used |
| 58 |
Nimesulide Mouth dissolving Tablets (Not for Children bleow the age of 12 years |
Each Mouth dissolving tablet contains:- Nimesulide BP 100 mg Excipients q.s Approved colour used |
| 59 |
Cetirizine Hydrochloride , Paracetamol, Phenylephrine Hydrochloride & caffeine Tablets |
Each uncoated tablet contains:- Cetirizine Hydrochloride IP 5 mg Paracetamol IP 325 mg Phenylephrine Hydrochloride IP 5 mg caffeine (Anhydrous) IP 30 mg Excipients q.s Approved colour used |
| 60 |
Paracetamol & Dicyclomine Hydrochloride Tablets |
Each uncoated tablet contains:- Paracetamol IP 325 mg Dicyclomine Hydrochloride IP 20 mg Excipients q.s Approved colour used |
| 61 |
Levocetirizine Dihydrochloride , Paracetamol, Phenylephrine Hydrochloride & Ambroxol Hydrochloride Tablets |
Each uncoated tablet contains:- Levocetirizine Dihydrochloride IP 5 mg Paracetamol IP 325 mg Phenylephrine Hydrochloride IP 10 mg Ambroxol Hydrochloride IP 60 mg Excipients q.s Approved colour used |
| 62 |
Piroxicam Tablets (DT) |
Each uncoated dispersible tablet contains:- Piroxicam IP 20 mg Excipients q.s Approved colour used |
| 63 |
Azathioprine Tablets IP |
Each uncoated tablet contains:- Azathioprine IP 50 mg Excipients q.s Approved colour used |
| 64 |
Tramadol Hydrochloride & Paracetamol Tablets |
Each uncoated tablet contains:- Tramadol Hydrochloride IP 50 mg Paracetamol IP 325 mg Excipients q.s Approved colour used |
| 65 |
Calcium Carbonate & Vitamin D3 Tablets |
Each film coated tablet contains:- Calcium Carbonate (Oyster shell) 1250 mg eq. to elemental calcium 500mg Vitamin D3 (Stabilised) IP 250 IU Excipients q.s Approved colour used |
| 66 |
Calcium Carbonate & Vitamin D3 Tablets |
Each film coated tablet contains:- Calcium Carbonate (Oyster shell) 625 mg eq. to elemental calcium 250mg Vitamin D3 (Stabilised) IP 125 IU Excipients q.s Approved colour used |
| 67 |
Repaglinide Tablets IP |
Each uncoated tablet contains:- Repaglinide IP 1 mg Excipients q.s Approved colour used |
| 68 |
Olanzapine Tablets IP |
Each uncoated tablet contains:- Olanzapine IP 2.5 mg Excipients q.s Approved colour used |
| 69 |
Olanzapine Tablets IP |
Each uncoated tablet contains:- Olanzapine IP 5 mg Excipients q.s Approved colour used |
| 70 |
Olanzapine Tablets IP |
Each uncoated tablet contains:- Olanzapine IP 7.5 mg Excipients q.s Approved colour used |
| 71 |
Olanzapine Tablets IP |
Each uncoated tablet contains:- Olanzapine IP 10 mg Excipients q.s Approved colour used |
| 72 |
Levocetirizine Dihydrochloride & Ambroxol Hydrochloride Tablets |
Each uncoated tablet contains:- Levocetirizine Dihydrochloride IP 5 mg Ambroxol Hydrochloride IP 60 mg Excipients q.s Approved colour used |
| 73 |
Methylcobalamin Tablets |
Each film coated tablet contains:- Methylcobalamin USP 500 mcg Excipients q.s Approved colour used |
| 74 |
Methylcobalamin Tablets |
Each film coated tablet contains:- Methylcobalamin USP 1500 mcg Excipients q.s Approved colour used |
| 75 |
Isoxsuprine Hydrochloride Tablets IP |
Each uncoated tablet contains:- Isoxsuprine Hydrochloride IP 20 mg Excipients q.s Approved colour used |
| 76 |
Gliclazide & Metformin Hydrochloride Tablets |
Each film coated tablet contains:- Gliclazide IP 80 mg Metformin Hydrochloride IP 500 mg Excipients q.s Approved colour used |
| 77 |
Ondansetron Tablets IP |
Each film coated tablet contains:- Ondansetron Hydrochloride IP eq. to Ondansetron 8 mg Excipients q.s Approved colour used |
| 78 |
Loratadine Tablets USP |
Each uncoated tablet contains:- Loratadine USP 10 mg Excipients q.s Approved colour used |
| 79 |
Etoricoxib Tablets IP |
Each film coated tablet contains:- Etoricoxib IP 90 mg Excipients q.s Approved colour used |
| 80 |
Etoricoxib Tablets IP |
Each film coated tablet contains:- Etoricoxib IP 120 mg Excipients q.s Approved colour used |
| 81 |
Aceclofenac & Serratiopeptidase Tablets |
Each film coated tablet contains:- Aceclofenac IP 100 mg Serratiopeptidase IP 15 mg eq. to 30000 units of enzymetic activity (as enteric coated granules) Excipients q.s Approved colour used |
| 82 |
Tranexamic Acid & Etamsylate Tablets |
Each uncoated tablet contains:- Tranexamic Acid IP 250 mg Etamsylate BP 250 mg Excipients q.s Approved colour used |
| 83 |
Cetirizine Hydrochloride , Paracetamol, Phenylephrine Hydrochloride & Caffeine Tablets |
Each uncoated tablet contains:- Cetirizine Dihydrochloride IP 5 mg Paracetamol IP 325 mg Phenylephrine Hydrochloride IP 5 mg caffeine (Anhydrous) IP 30 mg Excipients q.s Approved colour used |
| 84 |
Chlorpheniramine Maleate , Paracetamol, Phenylephrine Hydrochloride & Caffeine tablets |
Each uncoated tablet contains:- Chlorpheniramine Maleate IP 2 mg Paracetamol IP 325 mg Phenylephrine Hydrochloride IP 5 mg caffeine (Anhydrous) IP 30 mg Excipients q.s Approved colour used |
| 85 |
Gabapentin & Methylcobalamin Tablets |
Each film coated tablet contains:- Gabapentin IP 300 mg Methylcobalamin USP 500 mcg Excipients q.s Approved colour used |
| 86 |
Methylcobalamin, Pyridoxine Hydrochloride, Folic Acid & Alpha Lipoic Acid Tablets |
Each film coated tablet contains:- Methylcobalamin USP 1500 mcg Pyridoxine Hydrochloride IP 3 mg Folic Acid IP 1.5 mg Alpha Lipoic Acid USP 100 mg Approved colour used . |
| 87 |
Nimesulide, Paracetamol & Magnesium Trisillicate Tablets (Not for Children bleow the age of 12 years |
Each uncoated tablet contains:- Nimesulide BP 100 mg Paracetamol IP 325 mg Magnesium Trisillicate IP 100 mg Excipients q.s Approved colour used |
| 88 |
Diclofenac Potassium, Paracetamol & Magnesium Trisillicate Tablets |
Each uncoated tablet contains:- Diclofenac Potassium BP 50 mg Paracetamol IP 325 mg Magnesium Trisillicate IP 100 mg Excipients q.s Approved colour used |
| 89 |
Betahistine Hydrochloride Tablets IP |
Each uncoated tablet contains:- Betahistine Hydrochloride IP 16 mg Excipients q.s Approved colour used |
| 90 |
Cetirizine Tablets IP |
Each film coated tablet contains:- Cetirizine Dihydrochloride IP 5 mg Excipients q.s Approved colour used |
| 91 |
Diclofenac Potassium & Metaxalone Tablets |
Each uncoated tablet contains:- Diclofenac Potassium BP 50 mg Metaxalone IP 400 mg Excipients q.s Approved colour used |
| 92 |
Paracetamol & Domperidone Tablets |
Each uncoated tablet contains:- Paracetamol IP 325 mg Domperidone IP 20 mg Excipients q.s Approved colour used |
| 93 |
Ursodeoxycholic Acid Tablets IP |
Each film coated tablet contains:- Ursodeoxycholic Acid IP 300 mg Excipients q.s Approved colour used |
| 94 |
Amitriptyline Hydrochloride Tablets IP |
Each film coated tablet contains:- Amitriptyline Hydrochloride IP 10 mg Excipients q.s Approved colour used |
| 95 |
Escitalopram Oxalate & Clonazepam Tablets |
Each film coated tablet contains:- Escitalopram Oxalate IP eq. to Escitalopram 10mg Clonazepam IP 0.5 mg Excipients q.s Approved colour used |
| 96 |
Ferrous Ascorbate, Folic Acid & Zinc Tablets |
Each film coated tablet contains:- Ferrous Ascorbate eq. to elemental Iron 100mg Folic Acid IP 1.5 mg Zinc Sulphate Monohydrate IP eq. to elemental Zinc 22.5 mg Excipients q.s Approved colour used |
| 97 |
Aciclovir Dispersible Tablets IP |
Each uncoated Dispersible tablet contains:- Aciclovir IP 200 mg Excipients q.s Approved colour used |
| 98 |
Aciclovir Dispersible Tablets IP |
Each uncoated Dispersible tablet contains:- Aciclovir IP 400 mg Excipients q.s Approved colour used |
| 99 |
Aciclovir Dispersible Tablets IP |
Each uncoated Dispersible tablet contains:- Aciclovir IP 800 mg Excipients q.s Approved colour used |
| 100 |
Fexofenadine Hydrochloride Tablets IP |
Each film coated tablet contains:- Fexofenadine Hydrochloride IP 180 mg Excipients q.s Approved colour used |
| 101 |
Finasteride Tablets IP |
Each film coated tablet contains:- Finasteride IP 5 mg Excipients q.s Approved colour used |
| 102 |
Hydroxychloroquine Sulphate Tablets IP |
Each film coated tablet contains:- Hydroxychloroquine Sulphate IP 200 mg Excipients q.s Approved colour used |
| 103 |
Ranitidine Hydrochloride Ondansetron Tablets |
Each film coated tablet contains:- Ranitidine Hydrochloride IP Eq. to Ranitidine 150 mg Ondansetron Hydrochloride IP eq. to Ondansetron 4 mg Excipients q.s Approved colour used |
| 104 |
Tramadol Hydrochloride, Dicyclomine Hydrochloride & Domperidone Tablets |
Each film coated tablet contains:- Tramadol Hydrochloride IP 50 mg Dicyclomine Hydrochloride IP 10 mg Domperidone IP 10 mg Excipients q.s Approved colour used |
| 105 |
Drotaverine Hydrochloride Tablets IP |
Each uncoated tablet contains:- Drotaverine Hydrochloride IP 80 mg Excipients q.s Approved colour used |
| 106 |
Metformin & Glimepiride tablets |
Each uncoated tablet contains:- Glimepiride IP 2 mg Metformin Hydrochloride IP 500 mg Excipients q.s Approved colour used |
| 107 |
Cetirizine tablets IP |
Each film coated tablet contains:- Cetirizine Dihydrochloride IP 10 mg Excipients q.s Approved colour used |
| 108 |
Cefixime Tablets IP |
Each film coated tablet contains:- Cefixime IP eq. to Anhydrous cefixime 200 mg Excipients q.s Approved colour used |
| 109 |
Cefuroxime Axetil Tablets IP |
Each film coated tablet contains:- Cefuroxime Axetil IP eq. to Cefuroxime 500mg Excipients q.s Approved colour used |
| 110 |
Cefpodoxime Tablets IP |
Each uncoated dispersible tablet contains:- Cefpodoxime Proxetil IP eq. to Cefpodoxime 100mg Excipients q.s Approved colour used |
| 111 |
Cefpodoxime Tablets IP |
Each film coated tablet contains:- Cefpodoxime Proxetil IP eq. to Cefpodoxime 200 mg Excipients q.s Approved colour used |
| 112 |
Cefuroxime Axetil Tablets IP |
Each film coated tablet contains:- Cefuroxime Axetil IP eq. to Cefuroxime 250mg Excipients q.s Approved colour used |
| 113 |
Cefixime Tablets IP |
Each uncoated dispersible tablet contains:- Cefixime IP eq. to Anhydrous cefixime 100mg Excipients q.s Approved colour used |
| 114 |
Cefixime Tablets IP |
Each uncoated dispersible tablet contains:- Cefixime IP eq. to Anhydrous cefixime 200 mg Excipients q.s Approved colour used |
| 115 |
Amoxycillin Dispersible Tablets IP |
Each uncoated dispersible tablet contains:- Amoxycillin Trihydrate IP eq. to Amoxycillin 250mg Excipients q.s Approved colour used |
| 116 |
Cefixime Tablets IP |
Each film coated tablet contains:- Cefixime IP eq. to Anhydrous cefixime 100mg Excipients q.s Approved colour used |
| 117 |
Cefixime Tablets IP |
Each film coated tablet contains:- Cefixime IP eq. to Anhydrous cefixime 50 mg Excipients q.s Approved colour used |
| 118 |
Cephalexin Tablets IP |
Each film coated tablet contains:- Cephalexin IP eq. to Anhydrous Cephalexin 500mg Excipients q.s Approved colour used |
| 119 |
Amoxycillin and Potassium Clavulanate Tablets IP |
Each film coated tablet contains:- Amoxycillin Trihydrate IP eq. to Amoxycillin 500mg Potassium Clavulanate diluted IP eq. to Clavulanic Acid 125mg Excipients q.s Approved colour used |
| 120 |
Cephalexin Tablets IP |
Each film coated tablet contains:- Cephalexin IP eq. to Anhydrous Cephalexin 600 mg Excipients q.s Approved colour used FOR VETERINARY USE ONLY |
| 121 |
Ofloxacin & Ornidazole Oral Suspension |
Each 5ml contains:- Ofloxacin IP 50 mg Ornidazole IP 125 mg Flavoured Syrupy base q.s Approved colour used . |
| 122 |
Cyproheptadine Hydrochloride & Tricholine Citrate Syrup |
Each 5ml contains:- Cyproheptadine Hydrochloride (Anhydrous) IP 2 mg Tricholine Citrate 2.5 mg Sorbitol Solution 70% Non Crystalizing IP 2 gm Flavoured Sorbitol base q.s Approved colour used |
| 123 |
Bromhexine Hydrochloride , Terbutaline Sulphate, Guaiphenesin & Menthol Syrup |
Each 5ml contains:- Bromhexine Hydrochloride IP 4 mg Terbutaline Sulphate IP 1.25 mg Guaiphenesin IP 50 mg Menthol IP 1 mg Flavoured Syrupy base q.s Approved colour used . |
| 124 |
Dextromethorphan Hydrobromide , Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup |
Each 5ml contains:- Dextromethorphan Hydrobromide IP 10 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Flavoured Syrupy base q.s Approved colour used |
| 125 |
Disodium Hydrogen Citrate Syrup |
Each 5ml contains:- Disodium Hydrogen Citrate BP 1.38 gm Flavoured Syrupy base q.s Approved colour used |
| 126 |
Paracetamol & Mefenamic Acid Suspension |
Each 5ml contains:- Paracetamol IP 125 mg Mefenamic Acid IP 50 mg Flavoured Syrupy base q.s Approved colour used . |
| 127 |
Sucralfate & Oxetacaine Suspension |
Each 5ml contains:- Sucralfate USP 1 gm Oxetacaine BP 10 mg Flavoured Sorbitol base q.s Approved colour used |
| 128 |
Albendazole Oral Suspension IP |
Each 5ml contains:- Albendazole IP 200 mg Flavoured Syrupy base q.s Approved colour used |
| 129 |
Azithromycin Oral Suspension IP |
Each 5ml contains:- Azithromycin Dihydrate IP eq. to Azithromycin Anhydrous 100mg Flavoured Syrupy base q.s Approved colour used |
| 130 |
Azithromycin Oral Suspension IP |
Each 5ml contains:- Azithromycin Dihydrate IP eq. to Azithromycin Anhydrous 200 mg Flavoured Syrupy base q.s Approved colour used |
| 131 |
Paracetamol, Phenylephrine Hydrochloride & Levocetirizine Dihydrochloride Suspension |
Each 5ml contains:- Paracetamol IP 250 mg Phenylephrine Hydrochloride IP 2.5 mg Levocetirizine Dihydrochloride IP 2.5 mg Flavoured Syrupy base q.s Approved colour used |
| 132 |
Dextromethorphan Hydrobromide , Phenylephrine Hydrochloride, Cetirizine Hydrochloride & Menthol Syrup |
Each 5ml contains:- Dextromethorphan Hydrobromide IP 10 mg Phenylephrine Hydrochloride IP 5 mg Cetirizine Hydrochloride IP 5 mg Menthol IP 1.5 mg Flavoured Syrupy base q.s Approved colour used |
| 133 |
Albendazole & Ivermectin Oral Suspension |
Each 5ml contains:- Albendazole IP 200 mg Ivermectin IP 1.5 mg Flavoured Syrupy base q.s Approved colour used |
| 134 |
Paracetamol & Aceclofenac Suspension |
Each 5ml contains:- Paracetamol IP 125 mg Aceclofenac IP 50 mg Flavoured Syrupy base q.s Approved colour used . |
| 135 |
Lactulose Solution USP |
Each 5ml contains:- Lactulose Concentrate USP eq. to Lactulose 3.35 gm In a Palatable base q.s 136 Ferric Ammonium Citrate, Folic Acid & Vitamin B12 Syrup |
| 136 |
Calcium Carbonate, Vitamim D3 & Zinc Sulphate Suspension |
Each 15ml contains:- Ferric Ammonium Citrate IP 160 mg eq. to Elemental Iron 32.8 mg Folic Acid IP 0.75 mg Vitamin B12 IP 5 mcg Flavoured Syrupy base q.s Approved colour used For Therapeutic use |
| 137 |
Magaldrate and Simethicone Oral Suspension USP |
Each 5ml contains:- Magaldrate (Anhydrous) IP 400 mg Simethicone Emulsion USP 60 mg Flavoured Sorbitol base q.s Approved colour used |
| 138 |
Calcium Carbonate, Vitamim D3 & Zinc Sulphate Suspension |
Each 5ml contains:- Calcium Carbonate (Oyster shell) 625 mg eq. to elemental calcium 250mg Vitamim D3 IP 400 IU Zinc Sulphate Monohydrate IP eq. to elemental Zinc 7.5 mg Flavoured Sorbitol base q.s Approved colour used |
| 139 |
L-Ornithine L-Aspartate, Nicotinamide & Riboflavin Sodium Phosphate Syrup |
Each 5ml contains:- L-Ornithine L-Aspartate 250mg Nicotinamide IP 20 mg Riboflavin Sodium Phosphate IP 1.72 mg Flavoured Syrupy base q.s Approved colour used FOR PROPHYLACTIC USE |
| 140 |
“Paracetamol Paediatric Oral Suspension IP” |
Each 5ml contains:- Paracetamol IP 250 mg Flavoured Syrupy base q.s Approved colour used . |
| 141 |
Ambroxol Hydrochloride, , Terbutaline Sulphate, Guaiphenesin & Menthol Syrup |
Each 5ml contains:- Ambroxol Hydrochloride, IP 15 mg Terbutaline Sulphate IP 1.25 mg Guaiphenesin IP 50 mg Menthol IP 2.5 mg Flavoured Syrupy base q.s Approved colour used . |
| 142 |
Artemether & Lumefantrine Syrup |
Each 5ml contains:- Artemether IP 20 mg Lumefantrine 120 mg Flavoured Syrupy base q.s Approved colour used |
| 143 |
Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension |
Each 5ml contains:- Paracetamol IP 250 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Flavoured Syrupy base q.s Approved colour used |
| 144 |
Ferrous Ascorbate & Folic Acid Suspension |
Each 5ml contains:- Ferrous Ascorbate Eq. to Elemental Iron 30 mg Folic Acid IP 550 mcg Flavoured Syrupy base q.s Approved colour used |
| 145 |
Dextromethorphan Hydrobromide , Phenylephrine Hydrochloride, Cetirizine Hydrochloride, Zinc Gluconate & Menthol Syrup |
Each 5ml contains:- Dextromethorphan Hydrobromide IP 5 mg Phenylephrine Hydrochloride IP 2.5 mg Cetirizine Hydrochloride IP 2.5 mg Zinc Gluconate IP 7.5 mg Menthol IP 2.5 mg Flavoured Syrupy base q.s Approved colour used |
| 146 |
Ambroxol Hydrochloride, Levosalbutamol & Guaiphenesin Syrup |
Each 5ml contains:- Ambroxol Hydrochloride IP 15 mg Levosalbutamol Hydrochloride IP eq. to Levosalbutamol 0.5 mg Guaiphenesin IP 50 mg Flavoured Syrupy base q.s Approved colour used |
| 147 |
Dextromethorphan Hydrobromide , Guaiphenesin, Chlorpheniramine Maleate & Ammonium Chloride Syrup |
Each 5ml contains:- Dextromethorphan Hydrobromide IP 5 mg Guaiphenesin IP 50 mg Chlorpheniramine Maleate IP 2.5 mg Ammonium Chloride IP 60 mg Flavoured Syrupy base q.s Approved colour used |
| 148 |
Magaldrate, Simethicone & Oxetacaine Oral Suspension |
Each 5ml contains:- Magaldrate (Anhydrous) IP 540 mg Simethicone Emulsion USP 50 mg Oxetacaine BP 10 mg Flavoured Sorbitol base q.s Approved colour used |
| 149 |
Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Drops |
Each ml contains:- Paracetamol IP 125 mg Phenylephrine Hydrochloride IP 2.5 mg Chlorpheniramine Maleate IP 1 mg Flavoured Syrupy base q.s Approved colour used |
| 150 |
Paracetamol Paediatric Oral Suspension IP |
Each ml contains:- Paracetamol IP 125 mg Flavoured Syrupy base q.s Approved colour used |
| 151 |
Ofloxacin & Nitazoxanide Oral Suspension |
Each 5ml contains:- Ofloxacin IP 50 mg Nitazoxanide 100mg Flavoured Syrupy base q.s Approved colour used . |
| 152 |
Ambroxol Hydrochloride, Levosalbutamol & Guaiphenesin Syrup |
Each 5ml contains:- Ambroxol Hydrochloride IP 30 mg Levosalbutamol Hydrochloride IP eq. to Levosalbutamol 1 mg Guaiphenesin IP 50 mg Flavoured Syrupy base q.s Approved colour used |
| 153 |
Carbonyl Iron , Folic Acid, Vitamin B12 & Zinc Sulphate Suspension |
Each 15ml contains:- Carbonyl Iron eq. to Elemental Iron 50 mg Folic Acid IP 1.5 mg Vitamin B12 IP 5 mcg Zinc Sulphate Monohydrate IP 61.8 mg Flavoured Syrupy base q.s FOR THERAPEUTIC USE |
| 154 |
“Paracetamol Paediatric Oral Suspension IP” |
Each 5ml contains:- Paracetamol IP 125 mg Flavoured Syrupy base q.s Approved colour used . |
| 155 |
Paracetamol Drops |
Each ml contains:- Paracetamol IP 125 mg Flavoured Syrupy base q.s Approved colour used . |
| 156 |
Levofloxacin & Bromhexine HCl Oral Solution |
Each ml contains:- levofloxacin Hemihydrate IP eq. to Levofloxacin 100mg Bromhexine Hydrochloride IP 7.5 mg Excipients q.s FOR VETERINARY USE ONLY |
| 157 |
Paracetamol, Phenylephrine Hydrochloride & Cetirizine Dihydrochloride Suspension |
Each 5ml contains:- Paracetamol IP 125 mg Phenylephrine Hydrochloride IP 5 mg Cetirizine Dihydrochloride IP 2.5 mg Flavoured Syrupy base q.s Approved colour used |
| 158 |
Sucralfate & Oxetacaine Suspension |
Each 10ml contains:- Sucralfate USP 1 gm Oxetacaine BP 20 mg Flavoured Sorbitol base q.s Approved colour used |
| 159 |
Sucralfate Suspension |
Each 10ml contains:- Sucralfate USP 1 gm Flavoured Sorbitol base q.s Approved colour used |
| 160 |
Cefpodoxime Oral Suspension IP |
Each 5ml contains after reconstitution with water Cefpodoxime Proxetil IP eq. to Cefpodoxime 50 mg Flavoured Syrupy base q.s Approved colour used |
| 161 |
Cefixime Oral Suspension IP |
Each 5ml contains after reconstitution with water Cefixime IP eq. to Anhydrous Cefixime 100mg Flavoured Syrupy base q.s Approved colour used |
| 162 |
Amoxycillin and Potassium Clavulanate Oral Suspension IP |
Each 5ml contains after reconstitution with water Amoxycillin Trihydrate IP eq. to Amoxycillin 200 mg Potassium Clavulanate diluted IP eq. to Clavulanic Acid 28.5 mg Flavoured Syrupy base q.s Approved colour used |
| 163 |
Amoxycillin Oral Suspension IP |
Each 5ml contains after reconstitution with water Amoxycillin Trihydrate IP eq. to Amoxycillin 125mg Flavoured Syrupy base q.s Approved colour used |
| 164 |
Cefixime Oral Suspension IP |
Each 5ml contains after reconstitution with water Cefixime IP eq. to Anhydrous cefixime 50 mg Flavoured Syrupy base q.s Approved colour used |
| 165 |
Cefpodoxime Oral Suspension IP |
Each 5ml contains after reconstitution with water Cefpodoxime Proxetil IP eq. to Cefpodoxime 100mg Flavoured Syrupy base q.s Approved colour used |
| 166 |
Amoxycillin and Potassium Clavulanate Oral Suspension IP |
Each 5ml contains after reconstitution with water Amoxycillin Trihydrate IP eq. to Amoxycillin 400 mg Potassium Clavulanate diluted IP eq. to Clavulanic Acid 57 mg Flavoured Syrupy base q.s Approved colour used |
| 167 |
Cefixime and Potassium Clavulanate for Oral Suspension |
Each 5ml contains after reconstitution with water Cefixime IP eq. to Anhydrous cefixime 50 mg Potassium Clavulanate diluted IP eq. to Clavulanic Acid 31.25 mg Flavoured Syrupy base q.s Approved colour used |
| 168 |
Cefpodoxime and Potassium Clavulanate for Oral Suspension |
Each 5ml contains after reconstitution with water Cefpodoxime Proxetil IP eq. to Cefpodoxime 50 mg Potassium Clavulanate diluted IP eq. to Clavulanic Acid 31.25 mg Flavoured Syrupy base q.s Approved colour used |
| 169 |
Amoxycillin, Potassium Clavulanate & Lactic Acid bacillus for Oral Suspension |
Each 5ml contains after reconstitution with water Amoxycillin Trihydrate IP eq. to Amoxycillin 200 mg Potassium Clavulanate diluted IP eq. to Clavulanic Acid 28.5 mg Lactic Acid bacillus 60 Million Spores Flavoured Syrupy base q.s Approved colour used |
| 170 |
Beclomethasone Dipropionate, Neomycin & Clotrimazole Cream |
Composition Beclomethasone Dipropionate IP 0.025% w/w Neomycin Sulphate IP 0.50% w/w Clotrimazole IP 1% w/w Chlorocresol IP 0.1% w/w Cream base q.s |
| 171 |
Clobetasol Propionate, Neomycin, Miconazole & Zinc Sulphate Cream |
Composition Clobetasol Propionate IP 0.050% w/w Neomycin Sulphate IP 0.50% w/w Miconazole Nitrate IP 2% w/w Zinc Sulphate IP 2% w/w Chlorocresol IP 0.1% w/w Cream base q.s 172 Fluticasone Cream IP Composition Fluticasone Propionate IP 0.05% w/w Cream base q.s |
| 173 |
Fluticasone Propionate, Neomycin, Miconazole & Zinc Sulphate Cream |
Composition Fluticasone Propionate IP 0.05% w/w Neomycin Sulphate IP 0.50% w/w Miconazole Nitrate IP 2.00% w/w Zinc Sulphate IP 2.00% w/w Cream base q.s |
| 174 |
Clobetasol Propionate, Neomycin & Clotrimazole Cream |
Composition Clobetasol Propionate IP 0.050% w/w Neomycin Sulphate IP 0.50% w/w Clotrimazole IP 1% w/w Chlorocresol IP 0.1% w/w Cream base q.s |
| 175 |
Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate & Menthol Gel |
Composition Diclofenac Diethylamine BP 1.16% w/w eq. to Diclofenac Sodium 1% w/w Linseed Oil BP 3% w/w Methyl Salicylate IP 10% w/w Menthol IP 5% w/w Benzyl Alcohol ( as Preservative) IP 1% w/w Gel Base q.s |
| 176 |
Aceclofenac, Capsaicin, Linseed Oil, Methyl Salicylate & Menthol Gel Composition Aceclofenac IP 1.50% w/w Capsaicin USP 0.01% w/w Linseed Oil BP 3.0% w/w Methyl Salicylate IP 10.0% w/w Menthol IP 5.0% w/w Benzyl Alcohol ( as Preservative) IP 1.0% w/w Gel Base q.s 177 |
Potassium Iodide, Iodine, Tannic Acid, Thymol, Menthol & Camphor Gum Paint Composition Potassium Iodide IP 2.00% w/v Iodine IP 1.00% w/w Tannic Acid BP 1.50% w/wThymol IP 0.25% w/wMenthol IP 0.25% w/w Camphor BP 0.25% w/wGlycerin IP q.s |
| 178 |
Potassium Nitrate & Sodium Monofluorophosphate Tooth Paste |
Composition Potassium Nitrate BP 5.00% w/w Sodium Monofluorophosphate USP 0.70% w/w Gel base q.s |
| 179 |
Chlorhexidine Mouthwash IP |
Composition Chlorhexidine Gluconate Solution IP Diluted to Chlorhexidine Gluonate 0.2% w/w Flavoured base q.s Approved Colour used |
| 180 |
Potassium Nitrate, Sodium Monofluorophosphate & Triclosan Tooth Paste |
Composition Potassium Nitrate BP 5.00% w/w Sodium Monofluorophosphate USP 0.70% w/w Triclosan USP 0.30% w/w Gel base q.s |
| 181 |
Beclomethasone Dipropionate, Neomycin & Clotrimazole Cream |
Composition Beclomethasone Dipropionate IP 0.025% w/w Neomycin Sulphate IP eq. to Neomycin 0.50% w/w Clotrimazole IP 1.00% w/w Chlorocresol IP 0.10% w/w Cream base q.s |
| 182 |
Clobetasol Cream IP |
Composition Clobetasol Propionate IP 0.05% w/w Cream base q.s |
| 183 |
Lactic Acid & Lactoserum (Topical Solution) |
Composition Lactic Acid IP 1.00% w/w Lactoserum 0.90% w/w ( For Topical use ) |
| 184 |
Avobenzone, Oxybenzone, Octinoxate & Zinc Oxide Lotion |
Composition Avobenzone USP 2.00% w/w Oxybenzone USP 3.0% w/w Octinoxate USP 7.5% w/w Octocrylene USP 3.0% w/w Zinc Oxide USP 2.0% w/w Lotion Base q.s |
| 185 |
Clobetasol Propionate & Salicylic Acid Ointment |
Composition Clobetasol Propionate IP 0.05% w/w Salicylic Acid IP 6.00% w/w Ointment base q.s |
| 186 |
Hydroquinone, Tretinoin & Mometasone Cream |
Composition Hydroquinone USP 2% w/w Tretinoin USP 0.025 w/w Mometasone Furoate IP 0.1% w/w Cream base q.s |
| 187 |
Mometasone & Fusidic acid Cream |
Composition Mometasone Furoate IP 0.1% w/w Fusidic acid IP 2.0% w/w Cream base q.s |
| 188 |
Mometasone Cream IP |
Composition Mometasone Furoate IP 0.1% w/w Cream base q.s |
| 189 |
Clindamycin & Tretinoin Gel |
Composition Clindamycin Phosphate IP eq. to Clindamycin 1.00% w/w Tretinoin USP 0.025% w/w Gel base q.s |
| 190 |
Clindamycin Gel USP |
Composition Clindamycin Phosphate IP eq. to Clindamycin 1.00% w/w Gel base q.s |
| 191 |
Mupirocin Ointment IP |
Composition Mupirocin IP 2% w/w Ointment base q.s |
| 192 |
Mometasone & Terbinafine Hydrochloride Cream |
Composition Mometasone Furoate IP 0.1% w/w Terbinafine Hydrochloride USP 1.0% w/w Cream base q.s |
| 193 |
Tretinoin Cream USP |
Composition Tretinoin USP 0.05% w/w Cream base q.s |
| 194 |
Halobetasol Propionate & Salicylic Acid Ointment |
Composition Halobetasol Propionate USP 0.05% w/w Salicylic Acid IP 6.00% w/w Ointment base q.s |
| 195 |
Ketoconazole Shampoo |
Composition Ketoconazole IP 2.00% w/wZinc Pyrithione 1.00% w/wshampoo Base q.s |
| 196 |
Lactic Acid & Lactoserum Topical Solution |
Composition Lactic Acid IP 1.0% w/wLactoserum 0.9% w/wLotion Base q.s |
| 197 |
Pantoprazole (EC) & Domperidone SR Capsules |
Each hard gelatin capsule contains:- Pantoprazole Sodium IP eq. to Pantoprazole 40mg (as enteric coated pellets) Domperidone IP 30 mg 10mg as immediate release 20mg as sustained release Approved colour used in empty capsule Shells. |
| 198 |
Rabeprazole (EC) & Domperidone SR Capsules |
Each hard gelatin capsule contains:- Rabeprazole Sodium IP 20 mg (as enteric coated pellets) Domperidone IP 30 mg 10mg as immediate release 20mg as sustained release Approved colour used in empty capsule Shells. |
| 199 |
Rabeprazole (EC) & Itopride SRCapsules |
Each hard gelatin capsule contains:- Rabeprazole Sodium IP 20 mg (as enteric coated pellets) Itopride Hydrochloride 150 mg (as sustained release pellets) Approved colour used in empty capsule Shells. |
| 200 |
Omeprazole Capsules IP |
Each hard gelatin capsule contains:- Omeprazole IP 20 mg (as enteric coated pellets) Approved colour used in empty capsule Shells. |
| 201 |
Omeprazole & Domperidone Capsules |
Each hard gelatin capsule contains:- Omeprazole IP 20 mg (as enteric coated pellets) Domperidone IP 10 mg (as coated pellets)Approved colour used in empty capsule Shells. |
| 202 |
Methylcobalamin, Pyridoxine Hydrochloride, Folic Acid, Benfotiamine & Alpha Lipoic Acid Capsules |
Each hard gelatin capsule contains:- Methylcobalamin IP 1500 mcg Pyridoxine Hydrochloride IP 3 mg Folic Acid IP 1.5 mg Benfotiamine IP 100 mg Alpha Lipoic Acid USP 100 mg Approved colour used in empty capsule Shells. |
| 203 |
Carbonyl Iron , Folic Acid, Vitamin B12 & Zinc Sulphate Capsule ( For therapeutic use) |
Each hard gelatin capsule contains:- Carbonyl Iron eq. to Elemental Iron 100mg Folic Acid IP 1 mg Vitamin B12 IP 15 mcg Zinc Sulphate Monohydrate IP 61.8 mg Approved colour used in empty capsule Shells. |
| 204 |
Methylcobalamin, Pyridoxine Hydrochloride, Folic Acid, Thiamine Mononitrate & Alpha Lipoic Acid Capsules |
Each hard gelatin capsule contains:- Methylcobalamin IP 1500 mcg Pyridoxine Hydrochloride IP 3 mg Folic Acid IP 1.5 mg Thiamine Mononitrate IP 10 mg Alpha Lipoic Acid USP 100 mg Approved colour used in empty capsule Shells. |
| 205 |
Methylcobalamin & Pregabalin Capsules |
Each hard gelatin capsule contains:- Methylcobalamin IP 500 mcg Pregabalin IP 75 mg Approved colour used in empty capsule Shells. |
| 206 |
Calcium Carbonate, Alfacalcidol & Zinc Capsules |
Each hard gelatin capsule contains:- Calcium Carbonate (Oyster shell) eq. to elemental calcium200 mg Calcitriol IP 0.25 mcg Zinc Sulphate Monohydrate IP eq. to elemental Zinc 7.5 mg Excipients q.s Approved colour used in empty capsule Shells. |
| 207 |
Cephalexin Capsules IP |
Each hard gelatin capsule contains:- Cephalexin IP eq. to Anhydrous Cephalexin 500mg Approved colour used in empty capsule Shells. |
| 208 |
Amoxycillin & Dicloxacillin Capsules |
Each hard gelatin capsule contains:- Amoxycillin Trihydrate IP eq. to Amoxycillin 250mg Dicloxacillin Sodium IP eq. to Dicloxacillin 250mg Approved colour used in empty capsule Shells. |
| 209 |
Amoxycillin Capsules IP |
Each hard gelatin capsule contains:- Amoxycillin Trihydrate IP eq. to Amoxycillin 500mg Approved colour used in empty capsule Shells. |
| 210 |
Amoxycillin Capsules IP |
Each hard gelatin capsule contains:- Amoxycillin Trihydrate IP eq. to Amoxycillin 250mg Approved colour used in empty capsule Shells. |
| 211 |
Amoxycillin, Cloxacillin & Lactic Acid bacillus Capsules |
Each hard gelatin capsule contains:- Amoxycillin Trihydrate IP eq. to Amoxycillin 250mg Cloxacillin Sodium IP eq. to Cloxacillin 250mg Lactic Acid bacillus 150 Million Spores Approved colour used in empty capsule Shells. |
| 212 |
Lycopene, Multivitamin & Minreals Syrup |
Each 10ml contains:- Lycopene (6%) USP 2000 mcg Niacinamide IP 25 mg Pyridoxine Hydrochloride IP 1.5 mg Cyanocobalamin IP 1 mcg Folic Acid IP 100 mcg Sodium Selenate eq. to Selenium 35 mcg Zinc Gluconate USP Eq. to elemental Zinc 3 mg Manganese Gluconate USP eq. to Manganese 2 mg Potassium Iodide IP eq. to Iodine 100 mcg Cupric Sulphate USP eq. to Copper 500 mcg Flavoured Syrupy base q.s Approved colour used FOR PROPHYLACTIC USE |
| 213 |
Lycopene, Betacarotene & Minreals Capsules |
Each hard gelatin capsule contains:- Lycopene (10%) Despersion USP 2500 mcg Betacarotene 20% Despersion BP 10 mg Sodium Selenate eq. to Selenium 150 mcg Zinc Sulphate Monohydrate IP Eq. to elemental Zinc 7.5 mg Manganese Sulphate USP eq. to Manganese 1.5 mg Copper Sulphate Anhydrous BP eq. to Copper 1 mg Approved colour used in empty capsule Shells. |
| 214 |
Multivitamins, Minreals & Ginseng Capsules (For Therapeutic Use only) |
Each hard gelatin capsule contains:- Powder Asiaan Ginseng USP 52.5 mg Vitamin D3 IP 500 IU vitamin B6 IP 3 mg Vitamin B12 IP 10 mcg Potassium Iodide IP 0.2 mg Lysine Hydrochloride USP 50 mg Zinc Sulphate Monohydrate IP 27 mg eq to Elemental Zinc 9.82 mg Magnesium Sulphate IP mg Selenium 50 mcg (as Sodium Selenate) Calcium Pantothenate IP 25 mg Approved colour used in empty capsule Shells. Dose:- 1 or 2 Capsules daily |
| 215 |
Multivitamin & Minreals Capsules |
Each hard gelatin capsule contains:- Niacinamide IP 100 mg Pyridoxine Hydrochloride IP 3 mg Biotin USP 100 mcg Folic Acid IP 1.5 mg Vitamin B12 IP 15 mcg Zinc Sulphate Monohydrate IP 41.4 mg Eq. to elemental Zinc 15.06 mg Sodium Selenite Pentahydrate BP eq. to Selenium 55 mcg Chromium 30 mcg (As Chromium Picolinate USP) Approved colour used in empty capsule Shells. FOR THERAPEUTIC USE |
| 216 |
Lycopene, Multivitamin & Minreals Syrup |
Each 5ml contains:- Lycopene (6%) USP 2000 mcg Niacinamide IP 25 mg Pyridoxine Hydrochloride IP 1.5 mg Cyanocobalamin IP 1 mcg Folic Acid IP 100 mcg Sodium Selenate eq. to Selenium 35 mcg Zinc Gluconate IP Eq. to elemental Zinc 3 mg Manganese Gluconate USP eq. to Manganese 2 mg Potassium Iodide IP eq. to Iodine 100 mcg Cupric Sulphate USP eq. to Copper 500 mcg Flavoured Syrupy base q.s Approved colour used FOR PROPHYLACTIC USE |
| 217 |
Protein Hydrolystate, Iron Choline Citrate, Thiamine Hydrochloride, Pyridoxine Hydrochloride, Cynocobalamin & Folic Acid Syrup |
Each 10ml contains:- Protein Hydrolystate (20%) 1 gm Iron Choline Citrate (66%) 100mg Thiamine Hydrochloride IP 4.5 mg Pyridoxine Hydrochloride IP 2 mg Cynocobalamin IP 10 mcg Folic Acid IP 1 mg Flavoured Syrupy base q.s For Therapeutic use |
| 218 |
Cefpodoxime Dispersible Tablets |
Each uncoated dispersible tablet contains:- Cefpodoxime Proxetil IP eq. to Cefpodoxime200 mg Excipients q.s Approved colour used |
| 219 |
Cephalexin dispersible Tablets |
Each uncoated dispersible tablet contains:- Cephalexin IP eq. to Anhydrous Cephalexin 250mg Excipients q.s Approved colour used |
| 220 |
Cefuroxime Axetil & Lactic Acid Bacillus Tablets |
Each film coated tablet contains:- Cefuroxime Axetil IP eq. to Cefuroxime 500mg Lactic Acid Bacillus IP 100 Million Spores Excipients q.s Approved colour used |
| 221 |
Cefuroxime Axetil & Lactic Acid Bacillus Tablets |
Each film coated tablet contains:- Cefuroxime Axetil IP eq. to Cefuroxime 250mg Lactic Acid Bacillus IP 100 Million Spores Excipients q.s Approved colour used |
| 222 |
Cefixime & Lactic Acid Bacillus dispersible Tablets |
Each uncoated dispersible tablet contains:- Cefixime IP eq. to Anhydrous cefixime 100mg Lactic Acid Bacillus IP 45 Million Spores Excipients q.s Approved colour used |
| 223 |
Amoxycillin & Lactic Acid Bacillus Dispersible Tablets |
Each uncoated dispersible tablet contains:- Amoxycillin Trihydrate IP eq. to Amoxycillin 250mg Lactic Acid Bacillus IP 60 Million Spores Excipients q.s Approved colour used |
| 224 |
Calcium Carbonate, Magnesium Hydroxide, Vitamin D3 & Zinc Sulphate Tablets |
Each film coated tablet contains:- Calcium Carbonate (Oyster shell) 1250 mg eq. to elemental Calcium 500mg Magnesium Hydroxide IP 90 mg Vitamin D3 (Stabilised) IP 400 IU Zinc Sulphate Monohydrate IP 4 mg Excipients q.s Approved colour used |
| 225 |
Calcium Carbonate, Vitamin D3 & Zinc Sulphate Tablets |
Each film coated tablet contains:- Calcium Carbonate (Oyster shell) 1250 mg eq. to elemental Calcium 500mg Vitamin D3 (Stabilised) IP 250 IU Zinc Sulphate Monohydrate IP eq. to elemental Zinc 7.5 mg Excipients q.s Approved colour used |
| 226 |
Azithromycin dispersible Tablets |
Each uncoated dispersible tablet contains:- Azithromycin Dihydrate IP eq. to Azithromycin Anhydrous 100mg Excipients q.s Approved colour used |
| 227 |
Doxylamine Succinate & Pyridoxine Hydrochloride Tablets |
Each enteric coated tablet contains:- Doxylamine succinate USP 10 mg Pyridoxine Hydrochloride IP 10 mg Excipients q.s Approved colour used |
| 228 |
Doxylamine Succinate , Pyridoxine Hydrochloride & Folic Acid Tablets |
Each enteric coated tablet contains:- Doxylamine succinate USP 10 mg Pyridoxine Hydrochloride IP 10 mg Folic Acid IP 1.5 mg Excipients q.s Approved colour used |
| 229 |
Ofloxacin & Lactic Acid Bacillus Tablets |
Each film coated tablet contains:- Ofloxacin IP 200 mg Lactic Acid Bacillus 60 Million Spores Excipients q.s Approved colour used |
| 230 |
Lornoxicam & Paracetamol Tablets |
Each film coated tablet contains:- Lornoxicam 8 mg Paracetamol IP 325 mg Excipients q.s Approved colour used |
| 231 |
Citicoline & Piracetam Tablets |
Each film coated tablet contains:- Citicoline Sodium IP Eq. to Citicoline 500mg Piracetam IP 400 mg Excipients q.s Approved colour used |
| 232 |
Febuxostat Tablets |
Each film coated tablet contains:- Febuxostat 40mg Excipients q.s Approved colour used |
| 233 |
Flunarizine, Domperidone & Paracetamol Tablets |
Each uncoated tablet contains:- Flunarizine Hydrochloride BP Eq. to Flunarizine 5 mg Domperidone IP 10 mg Paracetamol IP 325 mg Excipients q.s Approved colour used |
| 234 |
Roxithromycin & Ambroxol Hydrochloride Tablets |
Each film coated tablet contains:- Roxithromycin IP 150 mg Ambroxol Hydrochloride IP 30 mg Excipients q.s Approved colour used |
| 235 |
Nimesulide, Paracetamol & Chlorzoxazone Tablets (Not for Children bleow the age of 12 years |
Each film coated tablet contains:- Nimesulide BP 100 mg Paracetamol IP 325 mg Chlorzoxazone USP 250 mg Excipients q.s Approved colour used |
| 236 |
Cinnarizine & Domperidone Tablets |
Each uncoated tablet contains:- Cinnarizine IP 20 mg Domperidone IP 10 mg Excipients q.s Approved colour used |
| 237 |
Nimesulide, Dicyclomine Hcl Tablets (Not for Children bleow the age of 12 years |
Each uncoated tablet contains:- Nimesulide BP 100 mg Dicyclomine Hydrochloride IP 20 mg Excipients q.s Approved colour used |
| 238 |
Pantoprazole Tablets IP |
Each enteric coated tablet contains:- Pantoprazole Sodium IP eq. to Pantoprazole 20 mg Excipients q.s Approved colour used |
| 239 |
Cetirizine Dihydrochloride & Ambroxol Hydrochloride Tablets |
Each film coated tablet contains:- Cetirizine Dihydrochloride IP 5 mg Ambroxol Hydrochloride IP 60 mg Excipients q.s Approved colour used |
| 240 |
Mefenamic Acid tablets |
Each uncoated tablet contains:- Mefenamic Acid IP 100 mg Excipients q.s Approved colour used |
| 241 |
Piracetam Tablets |
Each film coated tablet contains:- Piracetam IP 400 mg Excipients q.s Approved colour used |
| 242 |
Mefenamic Acid & Dicyclomine Hydrochloride Tablets |
Each uncoated tablet contains:- Mefenamic Acid IP 250 mg Dicyclomine Hydrochloride IP 20 mg Excipients q.s Approved colour used |
| 243 |
Diclofenac Sodium & Paracetamol Tablets |
Each uncoated tablet contains:- Diclofenac Sodium IP 50 mg Paracetamol IP 325 mg Excipients q.s Approved colour used |
| 244 |
Ofloxacin dispersible Tablets |
Each uncoated dispersible tablet contains:- Ofloxacin IP 100 mg Excipients q.s Approved colour used |
| 245 |
Nimesulide, Paracetamol & Serratiopeptidase Tablets (Not for Children bleow the age of 12 years |
Each uncoated tablet contains:- Nimesulide BP 100 mg Paracetamol IP 325 mg Serratiopeptidase IP 10 mg eq. to 20000 units of enzymetic activity (as enteric coated granules) Excipients q.s Approved colour used |
| 246 |
Nimesulide, Paracetamol & Serratiopeptidase Tablets (Not for Children bleow the age of 12 years |
Each uncoated tablet contains:- Nimesulide BP 100 mg Paracetamol IP 325 mg Serratiopeptidase IP 15 mg eq. to 30000 units of enzymetic activity (as enteric coated granules) Excipients q.s Approved colour used |
| 247 |
Rosuvastatin Calcium Tablets IP |
Each film coated tablet contains:- Rosuvastatin Calcium IP Eq. to Rosuvastatin 5 mg Excipients q.s Approved colour used |
| 248 |
Rosuvastatin Calcium Tablets IP |
Each film coated tablet contains:- Rosuvastatin Calcium IP Eq. to Rosuvastatin 10mg Excipients q.s Approved colour used |
| 249 |
Drotaverine Hydrochloride Tablets IP |
Each film coated tablet contains:- Drotaverine Hydrochloride IP 80 mg Excipients q.s Approved colour used |
| 250 |
Paracetamol Tablets IP |
Each uncoated tablet contains:- Paracetamol IP 650 mg Excipients q.s Approved colour used |
| 251 |
Rabeprazole (EC) & Aceclofenac SR Capsules |
Each hard gelatin capsule contains:- Rabeprazole Sodium IP 20 mg (as enteric coated pellets) Aceclofenac IP 200 mg (as sustained release pellets) Approved colour used in empty capsule Shells. |
| 252 |
Methylcobalamin , Pregabalin, Alpha Lipoic Acid, Pyridoxine Hydrochloride & Folic Acid Capsules |
Each hard gelatin capsule contains:- Methylcobalamin IP 750 mcg Pregabalin IP 75 mg Alpha Lipoic Acid USP 100 mg Pyridoxine Hydrochloride IP 3 mg Folic Acid IP 1.5 mg Excipients q.s Approved colour used in empty capsule Shells. |
| 253 |
Clobetasol Propionate, Salicylic Acid,Urea, Lactic Acid & Sodium Lactate Solution Ointment |
Composition Clobetasol Propionate IP 0.050% w/w Salicylic Acid IP 3.000% w/w Urea IP 10.00% w/w Lactic Acid IP 3.00% w/w Sodium Lactate Solution USP eq. to Lactic Acid IP 2.0% w/w Ointment base q.s |
| 254 |
Beclomethasone Dipropionate & Clotrimazole Cream Composition Beclomethasone Dipropionate IP 0.025% w/w Clotrimazole IP 1.00% w/w Cream base q.s 2.5 Gammabenzene & Cetirimide Lotion |
Composition Gamma benzene Hexachloride IP 1.00% w/w Cetrimide IP 0.10% w/w Lotion Base q.s |
| 256 |
Clotrimazole Cream IP |
Composition Clotrimazole IP 1.00% w/w Chlorocresol IP 0.10% w/w Cream base q.s |
| 257 |
Metronidazole & Chlorhexidine Glulonate Oral gel |
Composition Metronidazole Benzoate IP eq. to Metronidazole 1.00% w/w Chlorhexidine Glulonate Solution IP 0.25% w/w Gel base q.s Approved colour used |
| 258 |
Cefixime & Lactic Acid Bacillus Oral Suspension |
Each 5ml contains after reconstitution with water Cefixime IP eq. to Anhydrous cefixime 50 mg Lactic Acid Bacillus IP 20 Million Spores Flavoured base q.s Approved colour used |
| 259 |
Cephalexin Oral Suspension IP |
Each 5ml contains after reconstitution with water Cephalexin IP eq. to Anhydrous Cephalexin 125mg Flavoured base q.s Approved colour used |
| 260 |
Cefixime & Lactic Acid Bacillus Oral Suspension |
Each 5ml contains after reconstitution with water Cefixime IP eq. to Anhydrous cefixime 50 mg Lactic Acid Bacillus IP 30 Million Spores Flavoured base q.s Approved colour used |
| 261 |
Amoxycillin, Potassium Clavulanate & Lactic Acid bacillus for Oral Suspension |
Each 5ml contains after reconstitution with water Amoxycillin Trihydrate IP eq. to Amoxycillin 200 mg Potassium Clavulanate diluted IP eq. to Clavulanic Acid 28.5 mg Lactic Acid bacillus 20 Million Spores Flavoured Syrupy base q.s Approved colour used |
| 262 |
Diphenhydramine Hcl, Sodium Citrate, Ammonium Chloride & Menthol Syrup |
Each 5ml contains:- Diphenhydramine Hydrochloride IP 14.08 mg Sodium Citrate IP 57.03 mg Ammonium Chloride IP 138 mg Menthol IP 1 mg Flavoured Syrupy base q.s Approved colour used |
| 263 |
Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup |
Each 5ml contains:- Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg Flavoured Syrupy base q.s Approved colour used |
| 264 |
Magaldrate, Simethicone & Domperidone Oral Suspension |
Each 5ml contains:- Magaldrate (Anhydrous) IP 480 mg Simethicone Emulsion USP 20 mg Domperidone IP 10 mg Flavoured Sorbitol base q.s Approved colour used |
| 265 |
Magaldrate, Simethicone & Domperidone Oral Suspension |
Each 10ml contains:- Magaldrate (Anhydrous) IP 480 mg Simethicone Emulsion USP 20 mg Domperidone IP 10 mg Flavoured Sorbitol base q.s Approved colour used |
| 266 |
Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension |
Each 5ml contains:- Paracetamol IP 125 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 1 mg Flavoured suspension base q.s Approved colour used |
| 267 |
Piracetam Syrup |
Each 5ml contains:- Piracetam IP 500 mg Flavoured Syrupy base q.s Approved colour used |
| 268 |
Iron & Folic Acid Oral Drops |
Each ml contains:- Iron (III) Hydroxide Polymaltose Complex Eq. to Elemental Iron 50 mg Folic Acid IP 0.5 mg Flavoured Syrupy base q.s |
| 269 |
Calcium Lactate, Calcium Gluconate, Vitamin D3, Vitamin B12 & Lysine Hydrochloride Syrup |
Each 10ml contains:- Calcium Lactate IP 200 mg Calcium Gluconate IP 60 mg Vitamin D3 IP 400 IU Vitamin B12 IP 15 mcg Lysine Hydrochloride USP 15 mg Flavoured Syrupy base q.s Approved colour used |
| 270 |
Vitamin B1, Vitamin B2, Vitamin B6, Niacinamide & Lysine Hydrochloride Syrup |
Each 15ml contains:- Vitamin B1 IP 5 mg Vitamin B2 IP 5 mg Vitamin B6 IP 1.5 mg Niacinamide IP 50 mg Lysine Hydrochloride USP 100 mg Flavoured Syrupy base q.s Approved colour used FOR PROPHYLACTIC USE |
| 271 |
Calcium Carbonate & Vitamin D3 Suspension |
Each 5ml contains:- Calcium Carbonate (Oyster shell) 625 mg eq. to elemental Calcium 250mg Vitamin D3 IP 125 IU Flavoured Sorbitol base q.s Approved colour used |
| 272 |
Calcium Carbonate, Vitamin D3 & Lysine Hydrochloride Suspension |
Each 5ml contains:- Calcium Carbonate (Oyster shell) 375 mg eq. to elemental Calcium 150 mg Vitamin D3 IP 200 IU Lysine Hydrochloride USP 50 mg Flavoured Sorbitol base q.s Approved colour used |
| 273 |
Paracetramol & Promethazine Hydrochloride Suspension |
Each 5ml contains:- Paracetamol IP 125 mg Promethazine Hydrochloride IP 5 mg Flavoured Suspnesion base q.s Approved colour used |
| 274 |
Sucralfate & Oxetacaine Suspension |
Each 10ml contains:- Sucralfate USP 1 gm Oxetacaine BP 10 mg Flavoured Sorbitol base q.s Approved colour used |
| 275 |
2.5 Cetirizine Dihydrochloride , Dextromethorphan Hydrobromide & Menthol Syrup |
Each 5ml contains:- Cetirizine Dihydrochloride IP 5 mg Dextromethorphan Hydrobromide IP 10 mg Menthol IP 1 mg Flavoured Syrupy base q.s Approved colour used |
| 276 |
Paracetamol, Dextromethorphan Hydrobromide , Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup |
Each 5ml contains:- Paracetamol IP 125 mg Dextromethorphan Hydrobromide IP 5 mg Phenylephrine Hydrochloride IP 2.5 mg Chlorpheniramine Maleate IP 2 mg Flavoured Syrupy base q.s Approved colour used |
| 277 |
Chlorpheniramine Maleate, Sodium Citrate, Ammonium Chloride & Menthol Syrup |
Each 5ml contains:- Chlorpheniramine Maleate IP 2.5 mg Sodium Citrate IP 55 mg Ammonium Chloride IP 125 mg Menthol IP 1 mg Flavoured Syrupy base q.s Approved colour used |
| 278 |
Dextromethorphan Hydrobromide , Bromhexine Hydrochloride, Guaiphenesin & Chlorpheniramine Maleate Syrup |
Each 5ml contains:- Dextromethorphan Hydrobromide IP 5 mg Bromhexine Hydrochloride IP 4 mg Guaiphenesin IP 50 mg Chlorpheniramine Maleate IP 2 mg Flavoured Syrupy base q.s Approved colour used |
| 279 |
Dextromethorphan Hydrobromide , Phenylephrine Hydrochloride, Chlorpheniramine Maleate & Guaiphenesin Syrup |
Each 5ml contains:- Dextromethorphan Hydrobromide IP 10 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 4 mg Guaiphenesin IP 100 mg Flavoured Syrupy base q.s Approved colour used |
| 280 |
Cyproheptadine Hydrochloride & Tricholine Citrate Syrup |
Each 5ml contains:- Cyproheptadine Hydrochloride(Anhydrous IP 2 mg Tricholine Citrate 2.5 mg Sorbitol Solution 70% Non Crystalizing IP q.s Flavoured Sorbitol base ; Approved colour used |
| 281 |
Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension |
Each 5ml contains:- Paracetamol IP 125 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 1 mg Flavoured Syrupy base q.s Approved colour used |
| 282 |
Paracetamol & Mefenamic Acid Suspension |
Each 5ml contains:- Paracetamol IP 250 mg Mefenamic Acid IP 100 mg Flavoured Syrupy base q.s Approved colour used . |
| 283 |
Omeprazole Magnesium & Ondansetron HCl Tablets |
Each enteric coated tablet contains:- Omeprazole Magnesium IP Eq. to Omeprazole 10mg Ondansetron Hydrochloride IP eq. to Ondansetron 4 mg Excipients q.s Approved colour used |
| 284 |
Nimesulide, Chlorpheniramine Maleate, Phenylephrine Hydrochloride & Caffeine Tablets |
Each uncoated tablet contains:- Nimesulide BP 100 mg Chlorpheniramine Maleate IP 4 mg PHENYLEPHRINE IP 5 mg caffeine (Anhydrous) IP 30 mg Approved colour used |
| 285 |
Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate , Capsaicin & Menthol Gel |
Composition Diclofenac Diethylamine BP 1.16% w/w eq. to Diclofenac Sodium 1% w/w Linseed Oil BP 3% w/w Methyl Salicylate IP 10% w/w Menthol IP 5% w/w Capsaicin USP 0.025% w/w Benzyl Alcohol ( as Preservative) IP 1% w/w Gel Base q.s |
| 286 |
Luliconazole Cream Composition |
Luliconazole 1% w/w Cream base q.s |
| 287 |
Deflazacort Suspension |
Each 5ml contains:- Deflazacort 6 mg Flavoured base q.s Approved colour used |
| 288 |
Cefpodoxime Proxetil and Potassium Clavulanate Tablets |
Each film coated tablet contains:- Cefpodoxime Proxetil IP eq. to Cefpodoxime 200 mgPotassium Clavulanate (diluted) IP eq. to Clavulanic Acid 125mg Excipients q.s Approved colour used |
| 289 |
Esomeprazole & Domperidone Capsules |
Each hard gelatin capsule contains:- Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40mg (as enteric coated pellets ) Domperidone IP 30 mg (as sustained release Pellets ) Excipients q.s Approved colour used in empty Capsule shells |
| 290 |
Moxifloxacin tablets |
Each film coated tablet contains:- Moxifloxacin Hydrochloride IP Eq. to Moxifloxacin 400 mg Excipients q.s Approved colour used |
| 291 |
Dexrabeprazole & Domperidone Capsules |
Each hard gelatin capsule contains:- Dexrabeprazole 10mg (as enteric coated pellets ) Domperidone IP 30 mg (as sustained release Pellets ) Excipients q.s Approved colour used in empty Capsule shells |
| 292 |
Esomeprazole & Domperidone Capsules |
Each hard gelatin capsule contains:- Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 20 mg (as enteric coated pellets ) Domperidone IP 30 mg (as sustained release Pellets ) Excipients q.s Approved colour used in empty Capsule shells |
| 293 |
Light Liquid Paraffin & White Soft Paraffin cream Composition |
Light Liquid Paraffin IP 6.0% w/w White Soft Paraffin IP 15.0% w/w Cream base q.s |
| 294 |
Rabeprazole & Levosulpride Capsules |
Each hard gelatin capsule contains:- Rabeprazole Sodium IP 20 mg (as enteric coated pellets ) Levosulpride IP 75 mg (as sustained release Pellets ) Excipients q.s Approved colour used in empty Capsule shells |
| 295 |
Metdylcobalamin, Pyridoxine Hydrochloride, Folic Acid, Vitamin D3 & Alpha Lipoic Acid tablets |
Each film coated tablet contains:- Metdylcobalamin USP 1500 mcg Pyridoxine Hydrochloride IP 3 mg Folic Acid IP 1.5 mg Vitamin D3 IP 1000 IU Alpha Lipoic Acid USP 100 mg Excipients q.s Approved colour used |
| 296 |
Diclofenac Dietdylamine, Linseed Oil, Metdyl Salicylate & Mentdol Gel Composition |
Diclofenac Dietdylamine BP 1.16% w/w eq. to Diclofenac Sodium 1% w/w Linseed Oil BP 3% w/w Metdyl Salicylate IP 10% w/w Mentdol IP 0.5% w/w Benzyl Alcohol ( as Preservative) IP 1% w/w Gel Base q.s |
| 297 |
Silver Sulphadiazine, Lignocaine & Chlorhexidine Glulonate cream Composition |
Silver Sulphadiazine IP 1.00% w/w Lignocaine IP 2.0% w/w Chlorhexidine Gluconate IP eq. to Chlorhexidine 0.2% w/w Cream base q.s |
| 298 |
Propranolol Hydrochloride (SR) & Flunarizine Dihydrochloride Capsules |
Each hard gelatin capsule contains:- Propranolol Hydrochloride IP 40 mg (as sustained release Pellets ) Flunarizine Dihydrochloride BP eq. to Flunarizine 10mg (as immediate release Pellets ) Excipients q.s Approved colour used in empty Capsule shells |
| 299 |
Glibenclamide & metformin (SR) tablets |
Each uncoated tablet contains Glibenclamide IP 5 mg Metformin Hydrochloride IP 850 mg (as sustained release ) Excipients q.s Approved colour used |
| 300 |
Glibenclamide & metformin (SR) tablets |
Each uncoated tablet contains Glibenclamide IP 5 mg Metformin Hydrochloride IP 500 mg (as sustained release ) Excipients q.s Approved colour used |
| 301 |
Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride tables |
Each uncoated tablet contains Paracetamol IP 325 mg Phenylephrine Hydrochloride IP 5 mg Caffeine (anhydrous) IP 30 mg Diphenhydramine Hydrochloride IP 25 mg Excipients q.s Approved colour used |
| 302 |
Atrovastin & Ezatimib tablets |
Each film coated tablet contains:- Atorvastatin Calcium IP eq. to Atorvastatin 10mg Ezatimib 10mg Excipients q.s Approved colour used |
| 303 |
Atrovastin & Ezatimib tablets |
Each film coated tablet contains:- Atorvastatin Calcium IP eq. to Atorvastatin 20 mg Ezatimib 10mg Excipients q.s Approved colour used |
| 304 |
Etodolac Tablets IP |
Each uncoated tablet contains:- Etodolac IP 400 mg Excipients q.s Approved colour used |
| 305 |
Etodolac & Thiocolchicoside Tablets |
Each uncoated tablet contains:- Etodolac IP 400 mg Thiocolchicoside IP 8 mg Excipients q.s Approved colour used |
| 306 |
Aceclofenac & ThiocolchicosideTablets |
Each film coated tablet contains:- Aceclofenac IP 100 mg Thiocolchicoside IP 8 mg Excipients q.s Approved colour used |
| 307 |
Aceclofenac & ThiocolchicosideTablets |
Each film coated tablet contains:- Aceclofenac IP 100 mg Thiocolchicoside IP 4 mg Excipients q.s Approved colour used |
| 308 |
Lornoxicam & Thiocolchicoside Tablets |
Each film coated tablet contains:- Lornoxicam 8 mg Thiocolchicoside IP 8 mg Excipients q.s Approved colour used |
| 309 |
Multivitamins tablets (For Prophylactic Use) |
Each film coated tablet contains:- Vitamin A (as Acetate) IP 2500 IU Vitamin D3 IP 200 IU Vitamin B1 IP 2 mg Vitamin B2 IP 2 mg Vitamin B6 IP 0.5 mg Calcium Pantotdenate IP 1 mg Niacinamide IP 25 mg Vitamin C (Coated) IP 50 mg Folic Acid IP 0.2 mg Excipients q.s Approved colour used Appropriate overages of Vitamins added to compensate loss on storage For Govt. Tender supply only |
| 310 |
Cefixime & Lactic Acid Bacillus Tablets |
Each uncoated dispersible tablet contains:- Cefixime IP eq. to Anhydrous Cefixime 200 mgLactic Acid Bacillus IP 2.5 Billion Spores Excipients q.s Approved colour used |
| 311 |
Cefixime & Ofloxacin Tablets |
Each film coated tablet contains:- Cefixime IP eq. to Anhydrous Cefixime 200 mgOfloxacin IP 200 mg Excipients q.s Approved colour used |
| 312 |
Cefixime & Ofloxacin Tablets |
Each film coated tablet contains:- Cefixime IP eq. to Anhydrous Cefixime 100 mg Ofloxacin IP 100 mg Excipients q.s Approved colour used |
| 313 |
Cefixime and Potassium Clavulanate for Oral Suspension |
Each 5ml contains after reconstitution witd water Cefixime IP eq. to Anhydrous cefixime 100 mg Potassium Clavulanate diluted IP eq. to Clavulanic Acid 62.5 mg Flavoured Syrupy base q.s Approved colour used |
| 314 |
Escitalopram Oxalate Tablets IP |
Each film coated tablet contains:- Escitalopram Oxalate IP eq. to Escitalopram 5 mg Excipients q.s Approved colour used |
| 315 |
Escitalopram Oxalate Tablets IP |
Each film coated tablet contains:- Escitalopram Oxalate IP eq. to Escitalopram 10mg Excipients q.s Approved colour used |
| 316 |
Cefpodoxime Proxetil and Potassium Clavulanate Tablets |
Each film coated tablet contains:- Cefpodoxime Proxetil IP eq. to Cefpodoxime 200 mgPotassium Clavulanate (diluted) IP eq. to Clavulanic Acid 125mg Excipients q.s Approved colour used |
| 317 |
Terbinafine Tablets USP |
Each uncoated tablet contains:- Terbinafine Hydrochloride USP Eq. to Terbinafine 250mg Excipients q.s Approved colour used |
| 318 |
Ketoconazole Tablets IP |
Each film coated tablet contains:- Ketoconazole IP 200 mg Excipients q.s Approved colour used |
| 319 |
Ketoconazole Cream Composition |
Ketoconazole IP 2.0% w/w Cream Base q.s |
| 320 |
Povidone Iodine & Ornidazole Ointment Composition |
Povidone Iodine IP 5.0% w/w eq. to available Iodine 0.5% w/w Ornidazole IP 1.0% w/w Ointment Base q.s |
| 321 |
Metronidazole, Sucralfate & Povidone Iodine Ointment Composition |
Metronidazole IP 1.0% w/w Sucralfate USP 7.0% w/w Povidone Iodine IP 5.0% w/w eq. to available Iodine 0.5% w/w Ointment Base |
| 322 |
Itraconazole Capsule |
Each hard gelatin capsule contains:- Itraconazole (as Pellets ) eq. to Itraconazole BP 100 mg Excipients q.s Approved colour used |
| 323 |
Itraconazole Capsule |
Each hard gelatin capsule contains:- Itraconazole (as Pellets ) eq. to Itraconazole BP 200 mg Excipients q.s Approved colour used |
| 324 |
Vitamin C Tablets IP |
Each uncoated tablet contains:- Vitamin C IP 100 mg Excipients q.s Approved colour used |
| 325 |
Prometdazine Theoclate Tablets IP |
Each film coated tablet contains Prometdazine Theoclate IP 25 mg Excipients q.s Approved colour used |
| 326 |
Cholecalciferol Tablets IP |
Each uncoated chewable tablet contains Cholecalciferol IP IP 60000 IU Approvedcolour used |
| 327 |
Bisacodyl Tablets IP |
Each enteric coated tablet contains Bisacodyl IP 5 mg Excipients q.s Approved colour used |
| 328 |
Disulfiram Tablets IP |
Each uncoated tablet contains Disulfiram IP 200 mg Excipients q.s Approved colour used |
| 329 |
Paracetamol Tablets IP |
Each uncoated tablet contains Paracetamol IP 500 mg Excipients q.s |
| 330 |
Diclofenac Sodium & Paracetamol Tablets |
Each uncoated tablet contains Diclofenac Sodium IP 50 mg Paracetamol BP 325 mg Excipients q.s |
| 331 |
Norfloxacin & Tinidazole Tablets |
Each film coated tablet contains Norfloxacin IP 400 mg Tinidazole IP 600 mg Excipients q.s Approved colour used |
| 332 |
Erytdromycin Stearate Tablets IP |
Each film coated tablet contains Erytdromycin Stearate IP equivalent to Erytdromycin 250mg Approved colour used |
| 333 |
Erytdromycin Stearate Tablets |
Each film coated tablet contains Erytdromycin Stearate IP equivalent to Erytdromycin 500mg Approved colour used |
| 334 |
Metformin Hydrochloride & Glimepride Tablets |
Each uncoated tablet contains Metformin Hydrochloride IP (As sustained release) 500mg Glimepride IP 2 mg Excipients………q.s Approvedcolour used |
| 335 |
Montelukast & Fexofenadine Hydrochloride Tablets |
Each uncoated tablet contains Montelukast Sodium IP eq. to Montelukast 10mg Fexofenadine Hydrochloride IP 120 mg Excipients………q.s Approved colour used |
| 336 |
Montelukast & Fexofenadine Hydrochloride Tablets |
Each film coated tablet contains Montelukast Sodium IP eq. to Montelukast 10mg Fexofenadine Hydrochloride IP 120 mg Excipients………q.s Approved colour used |
| 337 |
Cinnarizine Tablets |
Each uncoated tablet contains:- Cinnarizine IP 75 mg Excipients q.s Approved colour used |
| 338 |
Etizolam Tablets |
Each uncoated tablet contains:- Etizolam IP 0.5 mg Excipients q.s Approved colour used |
| 339 |
Disulfiram Tablets |
Each uncoated tablet contains Disulfiram IP 500 mg Excipients q.s Approved colour used |
| 340 |
Terbinafine Hydrochloride Cream 1.0% Composition |
Terbinafine Hydrochloride 1.0% w/w Cream Base………………..q.s |
| 341 |
Polymyxin B-Sulfate Bacitracin Zinc and Neomycin Ointment USP Composition |
Polymyxin B-Sulfate USP 5000 Units Bacitracin Zinc IP 400 Units Neomycin Sulphate IP 3400 Units Ointment base……………….q.s |
| 342 |
Permetdrin Cream Composition |
Permetdrin BP 5% w/w Cream Base……………………q.s |
| 343 |
Amorolfine Hydrochloride Cream Composition |
Amorolfine hydrochloride IP equivalent to Amorolfine 0.25% w/w Cream base……..q.s |
| 344 |
Sertaconazole Nitrate & Zinc Pyritdione Shampoo Composition |
Sertaconazole Nitrate BP 2% w/w Zinc Pyritdione 1.00% w/v Shampoo Base………………..q.s |
| 345 |
Tacrolimus Ointment Composition |
Tacrolimus 0.1% w/w Ointment Base………………..q.s |
| 346 |
Tacrolimus Ointment Composition |
Tacrolimus 0.03% w/w Ointment Base………………..q.s |
| 347 |
Clindamycin & Adapalene Gel Composition |
Clindamycin Phosphate IP Eq. to Clindamycin 1.0% w/w Adapalene IP 0.1% w/w Gel Base………………..q.s |
| 348 |
Adapalene & Benzoyl Peroxide Gel Composition |
Adapalene IP 0.1% w/w Benzoyl Peroxide IP 2.5% w/w Gel Base………………..q.s |
| 349 |
Clindamycin & Benzoyl Peroxide Topical Gel Composition |
Clindamycin Phosphate IP Eq. to Clindamycin 1.0% w/w Benzoyl Peroxide eq. to Anhydrous Benzoyl Peroxide IP 2.5% w/w Gel Base………………..q.s |
| 350 |
Ofloxacin oral Suspension |
Each 5 ml contains:- Ofloxacin IP 100 mg In flavoured syrup base q.s Approved coloured used |
| 351 |
Domperidone Suspension |
Each ml contains:- Domperidone IP 1 mg In flavoured syrup base q.s Colour: Ponceau 4R |
| 352 |
Ondansetron Oral solution IP |
Each 5ml contains:- Ondansetron Hydrochloride IP Equivalent to Ondansetron 2mg In flavoured syrup base q.s Colour: Ponceau 4R |
| 353 |
Dicyclomine & Dimetdicone Drop |
Each ml contains:- Dicyclomine Hydrochloride IP 10 mg Activated Dimetdicone IP 40 mg In flavoured syrup base…………..q.s |
| 354 |
Trioxsalen Tablets USP |
Each film coated tablet contains Trioxsalen USP 25 mg Excipients q.s Approved colour used |
| 355 |
Loperamide Hydrochloride Capsules IP |
Each Hard gelatin capsule contains Loperamide hydrochloride IP 2 mg Approved colours used in empty capsules |
| 356 |
Gabapentin tablets USP |
Each film coated tablet contains Gabapentin USP 300 mg Excipients q.s Approved colour used |
| 357 |
Clindamycin & Benzoyl Peroxide Topical Gel Composition |
Clindamycin Phosphate IP Eq. to Clindamycin 1.0% w/w Benzoyl Peroxide IP eq. to Anhydrous Benzoyl Peroxide 5.0% w/w Gel Base………………..q.s |
| 358 |
Aceclofenac & Diacerin Tablets |
Each film coated tablet contains:- Aceclofenac IP 100 mg Diacerin IP 50 mg Excipients q.s Approved colour used |
| 359 |
Amlodipine Besylate & Losartan Potasium Tablets IP |
Each film coated tablet contains:- Amlodipine Besylate IP eq.to Amlodipine 5 mg Losartan Potasium 50 mg Excipients q.s Approved colour used |
| 360 |
Diacerin, Metdyl Sulphonic Metdene & Glucosamine Sulphate Tablets |
Each film coated tablet contains:- Diacerin IP 50 mg Metdyl Sulphonic Metdene IP 250 mg Glucosamine Sulphate Potassium Chloride USP 750 mg Excipients q.s Approved colour used |
| 361 |
Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride tables |
Each uncoated tablet contains Paracetamol IP 500 mg Phenylephrine Hydrochloride IP 5 mg Caffeine (anhydrous) IP 30 mg Diphenhydramine Hydrochloride IP 25 mg Excipients q.s Approved colour used |
| 362 |
Sildenafil Tablets IP |
Each film coated tablet contains:- Sildenafil Citrate IP eq. to Sildenafil 50 mg Excipients q.s Approved colour used |
| 363 |
Sildenafil Tablets IP |
Each film coated tablet contains:- Sildenafil Citrate IP eq. to Sildenafil 100 mg Excipients q.s Approved colour used |
| 364 |
Metformin Hydrochloride & Glimepiride Tablets |
Each uncoated tablet contains Metformin Hydrochloride IP (As sustained release) 500mg Glimepiride IP 1 mg Excipients………q.s Approvedcolour used |
| 365 |
Acarbose Tablets IP |
Each film coated tablet contains:- Acarbose IP 50 mg Excipients q.s Approved colour used |
| 366 |
Acarbose Tablets IP |
Each film coated tablet contains:- Acarbose IP 100 mg Excipients q.s Approved colour used |
| 367 |
Citicholine & Piracetam Tablets |
Each film coated tablet contains:- Citicholine IP 500 mg Piracetam IP 400 mg Excipients q.s Approved colour used |
| 368 |
Etizolam Tablets |
Each uncoated tablet contains:- Etizolam IP 0.25 mg Excipients q.s Approved colour used |
| 369 |
Flunarizine Hydrochloride Tablets |
Each film coated tablet contains:- Flunarizine Hydrochloride BP Eq. to Flunarizine 10mg Excipients q.s Approved colour used |
| 370 |
Prochlorperazine Maleate Tablets IP |
Each uncoated tablet contains:- Prochlorperazine Maleate IP 5 mg Excipients q.s Approved colour used |
| 371 |
Luliconazole Lotion Composition |
Luliconazole1% w/w Lotion base q.s |
| 372 |
Ketoconazole Lotion Composition |
Ketoconazole IP 2% w/w Lotion base q.s |
| 373 |
Clotrimazole Lotion USP Composition |
Clotrimazole IP 1% w/w Non Aqueous base q.s |
| 374 |
Lignocaine Gel IP Composition |
Lignocaine Hydrochloride IP 1.00% w/w Gel base q.s |
| 375 |
Sertaconazole Nitrate Cream |
Composition:- Sertaconazole Nitrate BP 2.0% w/w Benzyl Alcohol IP 1.0% w/w Cream base q.s |
| 376 |
Desonide Cream |
Composition:- Desonide BP 0.05% w/w Cream base q.s |
| 377 |
Fusidic acid Cream IP Composition |
Fusidic acid IP 2.0% w/w Cream base q.s |
| 378 |
Clotrimazole Cream IP Composition |
Clotrimazole IP 2.00% w/w Chlorocresol IP 0.10% w/w Cream base q.s |
| 379 |
Miconazole Nitrate Cream IP |
Composition:- Miconazole Nitrate IP 2% w/w Chlorocresol 0.1% w/w Cream base q.s |
| 380 |
Beclometdasone Dipropionate & Neomycin Cream Composition |
Beclometdasone Dipropionate IP 0.025% w/w Neomycin Sulphate IP 0.50% w/w Cream base q.s |
| 381 |
Hydroxyzine Oral Solution IP |
Each 5 ml contains:- Hydroxyzine IP 10 mg In flavoured syrup base q.s Approved colour used |
| 382 |
Levocetirizine Dihydrochloride & Montelukast Syrup |
Each 5 ml contains:- Levocetirizine Dihydrochloride IP 2.5 mg Montelukast Sodium IP eq.to Montelukast 4 mg In flavoured syrup base q.s Approved colour used |
| 383 |
Cetirizine Syrup IP |
Each 5 ml contains:- Cetirizine Dihydrochloride IP 5 mg In flavoured syrup base q.s Approved colour used |
| 384 |
Sodium Picosulfate Oral Solution BP |
Each 5 ml contains:- Sodium Picosulfate BP 5 mg In flavoured syrup base q.s Approved colour used |
| 385 |
Doxycycline Hydrochloride & Lactic Acid bacillus Capsules |
Each hard gelatin capsule contains:- Doxycycline Hydrochloride IP 100 mg Lactic Acid bacillus IP 5 billion Spores Approvedcolour used in empty capsule Shells. |
| 386 |
Esomeprazole & Levosulpride Capsules |
Each hard gelatin capsule contains:- Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40mg (as enteric coated pellets ) Levosulpride IP 75 mg (as extended release Pellets ) Excipients q.s Approved colour used in empty Capsule shells |
| 387 |
Ampicillin & Dicloxacillin Capsules |
Each hard gelatin capsule contains:- Ampicillin Sodium IP eq. to Ampicillin 250mg Dicloxacillin Sodium IP eq. to Dicloxacillin 250mg Excipients q.s Approved colour used in empty Capsule shells |
| 388 |
Pantoprazole & Levosulpride Capsules |
Each hard gelatin capsule contains:- Pantoprazole Sodium IP eq. to Pantoprazole 40mg (as enteric coated pellets ) Levosulpride IP 75 mg (as extended release Pellets ) Excipients q.s Approved colour used in empty Capsule shells |
| 389 |
Acetazolamide Tablets IP |
Each film coated tablet contains:- Acetazolamide IP 250 mg Excipients q.s Approved colour used |
| 390 |
Chlorhexidine Gluconate Solution IP Composition |
Chlorhexidine Gluconate IP eq. to Chlorhexidine 2.0% w/w flavoured base q.s |
| 391 |
Neomycin Sulfate Cream USP Composition |
Neomycin Sulphate IP eq. to Neomycin 0.50% w/w Cream base q.s |
| 392 |
Lignocaine Gel IP Composition |
Lignocaine Hydrochloride IP 2.00% w/w Gel base q.s |
| 393 |
Tadalafil Tablets IP |
Each film coated tablet contains:- Tadalafil USP 20 mg Excipients q.s Approved colour used |
| 394 |
Tadalafil Tablets IP |
Each film coated tablet contains:- Tadalafil USP 10 mg Excipients q.s Approved colour used |
| 395 |
Ampicillin & Dicloxacillin Capsules |
Each hard gelatin capsule contains:- Ampicillin trihydrate IP eq. to Ampicillin 250mg Dicloxacillin Sodium IP eq. to Dicloxacillin 250mg Excipients q.s Approved colour used in empty Capsule shells |
| 396 |
Cyproheptadine Syrup IP |
Each 5ml contains:- Cyproheptadine Hydrochloride(Anhydrous) IP 2 mg Sorbitol Solution 70% Non Crystalizing IP q.s Flavoured Sorbitol base Approvedcolour used |
| 397 |
Eberconazole Nitrate Cream Composition |
Eberconazole Nitrate1% w/w Cream base q.s |
| 398 |
Ebastine Tablets |
Each film coated tablet contains:- Ebastine IP 10 mg Excipients q.s Approved colour used |
| 399 |
Amoxycillin & Lactic Acid bacillus Capsules |
Each hard gelatin capsule contains:- Amoxycillin Trihydrate IP eq. to Amoxycillin 500mg Lactic Acid bacillus 1.66 Billion Spores Excipients q.s Approved colour used in empty capsule Shells. |
| 400 |
Amoxycillin & Lactic Acid bacillus Capsules |
Each hard gelatin capsule contains:- Amoxycillin Trihydrate IP eq. to Amoxycillin 250mg Lactic Acid bacillus 1.66 Billion Spores Excipients q.s Approved colour used in empty capsule Shells. |
| 401 |
Linezolid Tablets IP |
Each film coated tablet contains:- Linezolid IP 600 mg Excipients q.s Approved colour used |
| 402 |
Povidone Iodine Ointment USP Composition |
Povidone Iodine IP 5.0% w/w eq. to available Iodine 0.5% w/w Ointment Base q.s |
| 403 |
Fluconazole Tablets IP |
Each uncoated tablet contains:- Fluconazole IP 50 mg Excipients q.s Approved colour used |
| 404 |
Oxytetracycline Hydrochloride Capsules IP |
Each hard gelatin capsule contains:- Oxytetracycline Hydrochloride IP 250 Approvedcolour used in empty capsule Shells. |
| 405 |
Oxytetracycline Hydrochloride Capsules IP |
Each hard gelatin capsule contains:- Oxytetracycline Hydrochloride IP 500 Approvedcolour used in empty capsule Shells. |
| 406 |
Esomeprazole gastro-resistant Tablets IP |
Each enteric coated tablet contains:- Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40mg Excipients q.s Approved colour used |
| 407 |
Ivermectin Tablets USP |
Each uncoated tablet contains:- Ivermectin IP 6 mg Excipients q.s Approved colour used |
| 408 |
Metformin Hydrochloride, Pioglitazone & Glimepride Tablets |
Each uncoated tablet contains Metformin Hydrochloride IP (As sustained release) 500mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Glimepride IP 2 mg Excipients………q.s Approvedcolour used |
| 409 |
Mupirocin Cream USP Composition |
Mupirocin IP 2% w/w Cream base q.s |
| 410 |
Levocetirizine Dihydrochloride & Ambroxol Hydrochloride Syrup |
Each 5 ml contains:- Levocetirizine Dihydrochloride IP 2.5 mg Ambroxol Hydrochloride IP 30 mg In flavoured syrup base q.s Approved colour used |
| 411 |
Levocetirizine Dihydrochloride & Ambroxol Hydrochloride Syrup |
Each 5 ml contains:- Levocetirizine Dihydrochloride IP 5 mg Ambroxol Hydrochloride IP 30 mg In flavoured syrup base q.s Approved colour used |
| 412 |
Cefpodoxime and Potassium Clavulanate for Oral Suspension |
Each 5ml contains after reconstitution witd water Cefpodoxime Proxetil IP eq. to Cefpodoxime 100 mg Potassium Clavulanate diluted IP eq. to Clavulanic Acid 62.5 mg Flavoured Syrupy base q.s Approved colour used |
| 413 |
Deflazacort Tablets |
Each uncoated tablet contains:- Deflazacort 12 mg Excipients q.s Approved colour used |
| 414 |
Esomeprazole (EC) & Itopride SR Capsules |
Each hard gelatin capsule contains:- Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40 mg (as enteric coated pellets) Itopride Hydrochloride 150 mg (as sustained release pellets) Approvedcolour used in empty capsule Shells. |
| 415 |
Pantoprazole (EC) & Itopride SR Capsules |
Each hard gelatin capsule contains:- Pantoprazole Sodium IP eq. to Pantoprazole 40 mg (as enteric coated pellets) Itopride Hydrochloride 150 mg (as sustained release pellets) Approvedcolour used in empty capsule Shells. |
| 416 |
Fluocinolone Acetonide Cream |
Composition Fluocinolone Acetonide IP 0.010 w/w Cream base q.s |
